3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-methylpyrazol-1-yl]benzoic acid;3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-phenylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-phenylpyrazol-1-yl]benzoic acid;4-[5-[[5-amino-1-[4-[5-amino-4-[[1-(2,5-dichloro-4-sulfophenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]-2,5-dichlorobenzenesulfonic acid;tetrakis(carbon dioxide)

C115H77Cl4N57O25S2 — CID 159053457

IUPAC3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-methylpyrazol-1-yl]benzoic acid;3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-phenylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-phenylpyrazol-1-yl]benzoic acid;4-[5-[[5-amino-1-[4-[5-amino-4-[[1-(2,5-dichloro-4-sulfophenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]-2,5-dichlorobenzenesulfonic acid;tetrakis(carbon dioxide)
SMILESO=C=O.O=C=O.O=C=O.O=C=O.[C-]#[N+]c1c(-c2ccccc2)nn(-c2cccc(C(=O)O)c2)c1/N=N/c1c(C)nn(-c2nc(O)nc(-n3nc(C)c(/N=N/c4c(C#N)c(-c5ccccc5)nn4-c4cccc(C(=O)O)c4)c3N)n2)c1N.[C-]#[N+]c1c(C)nn(-c2cccc(C(=O)O)c2)c1/N=N/c1c(C)nn(-c2nc(O)nc(-n3nc(C)c(/N=N/c4c(C#N)c(C)nn4-c4cccc(C(=O)O)c4)c3N)n2)c1N.[C-]#[N+]c1cnn(-c2cc(Cl)c(S(=O)(=O)O)cc2Cl)c1/N=N/c1c(C)nn(-c2nc(O)nc(-n3nc(C)c(/N=N/c4c(C#N)cnn4-c4cc(Cl)c(S(=O)(=O)O)cc4Cl)c3N)n2)c1N
InChIInChI=1S/C45H31N19O5.C35H27N19O5.C31H19Cl4N19O7S2.4CO2/c1-23-32(53-55-39-31(22-46)34(25-12-6-4-7-13-25)59-61(39)29-18-10-16-27(20-29)41(65)66)37(47)63(57-23)43-50-44(52-45(69)51-43)64-38(48)33(24(2)58-64)54-56-40-36(49-3)35(26-14-8-5-9-15-26)60-62(40)30-19-11-17-28(21-30)42(67)68;1-15-23(14-36)29(51(47-15)21-10-6-8-19(12-21)31(55)56)45-43-24-16(2)49-53(27(24)37)33-40-34(42-35(59)41-33)54-28(38)25(17(3)50-54)44-46-30-26(39-5)18(4)48-52(30)22-11-7-9-20(13-22)32(57)58;1-11-23(45-47-27-13(8-36)9-40-51(27)19-4-16(34)21(6-14(19)32)62(56,57)58)25(37)53(49-11)29-42-30(44-31(55)43-29)54-26(38)24(12(2)50-54)46-48-28-18(39-3)10-41-52(28)20-5-17(35)22(7-15(20)33)63(59,60)61;4*2-1-3/h4-21H,47-48H2,1-2H3,(H,65,66)(H,67,68)(H,50,51,52,69);6-13H,37-38H2,1-4H3,(H,55,56)(H,57,58)(H,40,41,42,59);4-7,9-10H,37-38H2,1-2H3,(H,56,57,58)(H,59,60,61)(H,42,43,44,55);;;;/b55-53+,56-54+;45-43+,46-44+;47-45+,48-46+;;;;
InChIKeyJXOKPDAFRXIAOE-WJQKIZDNSA-N
MW2863.20 g/mol
LogP17.58
Rot. Bonds32

About 3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-methylpyrazol-1-yl]benzoic acid;3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-phenylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-phenylpyrazol-1-yl]benzoic acid;4-[5-[[5-amino-1-[4-[5-amino-4-[[1-(2,5-dichloro-4-sulfophenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]-2,5-dichlorobenzenesulfonic acid;tetrakis(carbon dioxide)

3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-methylpyrazol-1-yl]benzoic acid;3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-phenylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-phenylpyrazol-1-yl]benzoic acid;4-[5-[[5-amino-1-[4-[5-amino-4-[[1-(2,5-dichloro-4-sulfophenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]-2,5-dichlorobenzenesulfonic acid;tetrakis(carbon dioxide) (PubChem CID 159053457) has the molecular formula C115H77Cl4N57O25S2 and a molecular weight of 2863.20 g/mol. Its IUPAC name is 3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-methylpyrazol-1-yl]benzoic acid;3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-phenylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-phenylpyrazol-1-yl]benzoic acid;4-[5-[[5-amino-1-[4-[5-amino-4-[[1-(2,5-dichloro-4-sulfophenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]-2,5-dichlorobenzenesulfonic acid;tetrakis(carbon dioxide).

Molecular Properties

Compound Name3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-methylpyrazol-1-yl]benzoic acid;3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-phenylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-phenylpyrazol-1-yl]benzoic acid;4-[5-[[5-amino-1-[4-[5-amino-4-[[1-(2,5-dichloro-4-sulfophenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]-2,5-dichlorobenzenesulfonic acid;tetrakis(carbon dioxide)
PubChem CID159053457
Molecular FormulaC115H77Cl4N57O25S2
Molecular Weight2863.20 g/mol
Exact Mass2859.47
IUPAC Name3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-methylpyrazol-1-yl]benzoic acid;3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-phenylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-phenylpyrazol-1-yl]benzoic acid;4-[5-[[5-amino-1-[4-[5-amino-4-[[1-(2,5-dichloro-4-sulfophenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]-2,5-dichlorobenzenesulfonic acid;tetrakis(carbon dioxide)
SMILESO=C=O.O=C=O.O=C=O.O=C=O.[C-]#[N+]c1c(-c2ccccc2)nn(-c2cccc(C(=O)O)c2)c1/N=N/c1c(C)nn(-c2nc(O)nc(-n3nc(C)c(/N=N/c4c(C#N)c(-c5ccccc5)nn4-c4cccc(C(=O)O)c4)c3N)n2)c1N.[C-]#[N+]c1c(C)nn(-c2cccc(C(=O)O)c2)c1/N=N/c1c(C)nn(-c2nc(O)nc(-n3nc(C)c(/N=N/c4c(C#N)c(C)nn4-c4cccc(C(=O)O)c4)c3N)n2)c1N.[C-]#[N+]c1cnn(-c2cc(Cl)c(S(=O)(=O)O)cc2Cl)c1/N=N/c1c(C)nn(-c2nc(O)nc(-n3nc(C)c(/N=N/c4c(C#N)cnn4-c4cc(Cl)c(S(=O)(=O)O)cc4Cl)c3N)n2)c1N
InChIInChI=1S/C45H31N19O5.C35H27N19O5.C31H19Cl4N19O7S2.4CO2/c1-23-32(53-55-39-31(22-46)34(25-12-6-4-7-13-25)59-61(39)29-18-10-16-27(20-29)41(65)66)37(47)63(57-23)43-50-44(52-45(69)51-43)64-38(48)33(24(2)58-64)54-56-40-36(49-3)35(26-14-8-5-9-15-26)60-62(40)30-19-11-17-28(21-30)42(67)68;1-15-23(14-36)29(51(47-15)21-10-6-8-19(12-21)31(55)56)45-43-24-16(2)49-53(27(24)37)33-40-34(42-35(59)41-33)54-28(38)25(17(3)50-54)44-46-30-26(39-5)18(4)48-52(30)22-11-7-9-20(13-22)32(57)58;1-11-23(45-47-27-13(8-36)9-40-51(27)19-4-16(34)21(6-14(19)32)62(56,57)58)25(37)53(49-11)29-42-30(44-31(55)43-29)54-26(38)24(12(2)50-54)46-48-28-18(39-3)10-41-52(28)20-5-17(35)22(7-15(20)33)63(59,60)61;4*2-1-3/h4-21H,47-48H2,1-2H3,(H,65,66)(H,67,68)(H,50,51,52,69);6-13H,37-38H2,1-4H3,(H,55,56)(H,57,58)(H,40,41,42,59);4-7,9-10H,37-38H2,1-2H3,(H,56,57,58)(H,59,60,61)(H,42,43,44,55);;;;/b55-53+,56-54+;45-43+,46-44+;47-45+,48-46+;;;;
InChIKeyJXOKPDAFRXIAOE-WJQKIZDNSA-N
XLogP17.58
TPSA1173.93 Ų
H-Bond Donors15
H-Bond Acceptors73
Rotatable Bonds32
Heavy Atoms203
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002863.20
LogP ≤ 517.58
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1073

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'azo_A(324)', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'diazo_group', 'substructure': 'N/A'}, {'alert_name': 'Sulfonic_acid_2', 'substructure': 'N/A'}

Analyze 3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-methylpyrazol-1-yl]benzoic acid;3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-phenylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-phenylpyrazol-1-yl]benzoic acid;4-[5-[[5-amino-1-[4-[5-amino-4-[[1-(2,5-dichloro-4-sulfophenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]-2,5-dichlorobenzenesulfonic acid;tetrakis(carbon dioxide) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-methylpyrazol-1-yl]benzoic acid;3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-phenylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-phenylpyrazol-1-yl]benzoic acid;4-[5-[[5-amino-1-[4-[5-amino-4-[[1-(2,5-dichloro-4-sulfophenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]-2,5-dichlorobenzenesulfonic acid;tetrakis(carbon dioxide)?
The IUPAC name of 3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-methylpyrazol-1-yl]benzoic acid;3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-phenylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-phenylpyrazol-1-yl]benzoic acid;4-[5-[[5-amino-1-[4-[5-amino-4-[[1-(2,5-dichloro-4-sulfophenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]-2,5-dichlorobenzenesulfonic acid;tetrakis(carbon dioxide) (CID 159053457) is 3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-methylpyrazol-1-yl]benzoic acid;3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-phenylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-phenylpyrazol-1-yl]benzoic acid;4-[5-[[5-amino-1-[4-[5-amino-4-[[1-(2,5-dichloro-4-sulfophenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]-2,5-dichlorobenzenesulfonic acid;tetrakis(carbon dioxide).
What is the SMILES notation for 3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-methylpyrazol-1-yl]benzoic acid;3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-phenylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-phenylpyrazol-1-yl]benzoic acid;4-[5-[[5-amino-1-[4-[5-amino-4-[[1-(2,5-dichloro-4-sulfophenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]-2,5-dichlorobenzenesulfonic acid;tetrakis(carbon dioxide)?
The canonical SMILES for 3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-methylpyrazol-1-yl]benzoic acid;3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-phenylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-phenylpyrazol-1-yl]benzoic acid;4-[5-[[5-amino-1-[4-[5-amino-4-[[1-(2,5-dichloro-4-sulfophenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]-2,5-dichlorobenzenesulfonic acid;tetrakis(carbon dioxide) is O=C=O.O=C=O.O=C=O.O=C=O.[C-]#[N+]c1c(-c2ccccc2)nn(-c2cccc(C(=O)O)c2)c1/N=N/c1c(C)nn(-c2nc(O)nc(-n3nc(C)c(/N=N/c4c(C#N)c(-c5ccccc5)nn4-c4cccc(C(=O)O)c4)c3N)n2)c1N.[C-]#[N+]c1c(C)nn(-c2cccc(C(=O)O)c2)c1/N=N/c1c(C)nn(-c2nc(O)nc(-n3nc(C)c(/N=N/c4c(C#N)c(C)nn4-c4cccc(C(=O)O)c4)c3N)n2)c1N.[C-]#[N+]c1cnn(-c2cc(Cl)c(S(=O)(=O)O)cc2Cl)c1/N=N/c1c(C)nn(-c2nc(O)nc(-n3nc(C)c(/N=N/c4c(C#N)cnn4-c4cc(Cl)c(S(=O)(=O)O)cc4Cl)c3N)n2)c1N.
What is the InChIKey of 3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-methylpyrazol-1-yl]benzoic acid;3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-phenylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-phenylpyrazol-1-yl]benzoic acid;4-[5-[[5-amino-1-[4-[5-amino-4-[[1-(2,5-dichloro-4-sulfophenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]-2,5-dichlorobenzenesulfonic acid;tetrakis(carbon dioxide)?
The InChIKey is JXOKPDAFRXIAOE-WJQKIZDNSA-N. The full InChI is InChI=1S/C45H31N19O5.C35H27N19O5.C31H19Cl4N19O7S2.4CO2/c1-23-32(53-55-39-31(22-46)34(25-12-6-4-7-13-25)59-61(39)29-18-10-16-27(20-29)41(65)66)37(47)63(57-23)43-50-44(52-45(69)51-43)64-38(48)33(24(2)58-64)54-56-40-36(49-3)35(26-14-8-5-9-15-26)60-62(40)30-19-11-17-28(21-30)42(67)68;1-15-23(14-36)29(51(47-15)21-10-6-8-19(12-21)31(55)56)45-43-24-16(2)49-53(27(24)37)33-40-34(42-35(59)41-33)54-28(38)25(17(3)50-54)44-46-30-26(39-5)18(4)48-52(30)22-11-7-9-20(13-22)32(57)58;1-11-23(45-47-27-13(8-36)9-40-51(27)19-4-16(34)21(6-14(19)32)62(56,57)58)25(37)53(49-11)29-42-30(44-31(55)43-29)54-26(38)24(12(2)50-54)46-48-28-18(39-3)10-41-52(28)20-5-17(35)22(7-15(20)33)63(59,60)61;4*2-1-3/h4-21H,47-48H2,1-2H3,(H,65,66)(H,67,68)(H,50,51,52,69);6-13H,37-38H2,1-4H3,(H,55,56)(H,57,58)(H,40,41,42,59);4-7,9-10H,37-38H2,1-2H3,(H,56,57,58)(H,59,60,61)(H,42,43,44,55);;;;/b55-53+,56-54+;45-43+,46-44+;47-45+,48-46+;;;;.
What are the key properties of 3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-methylpyrazol-1-yl]benzoic acid;3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-phenylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-phenylpyrazol-1-yl]benzoic acid;4-[5-[[5-amino-1-[4-[5-amino-4-[[1-(2,5-dichloro-4-sulfophenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]-2,5-dichlorobenzenesulfonic acid;tetrakis(carbon dioxide)?
3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-methylpyrazol-1-yl]benzoic acid;3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-phenylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-phenylpyrazol-1-yl]benzoic acid;4-[5-[[5-amino-1-[4-[5-amino-4-[[1-(2,5-dichloro-4-sulfophenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]-2,5-dichlorobenzenesulfonic acid;tetrakis(carbon dioxide) has a molecular weight of 2863.20 g/mol, XLogP of 17.58, 32 rotatable bonds, 15 hydrogen bond donors, and 73 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-methylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-methylpyrazol-1-yl]benzoic acid;3-[5-[[5-amino-1-[4-[5-amino-4-[[1-(3-carboxyphenyl)-4-isocyano-3-phenylpyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyano-3-phenylpyrazol-1-yl]benzoic acid;4-[5-[[5-amino-1-[4-[5-amino-4-[[1-(2,5-dichloro-4-sulfophenyl)-4-isocyanopyrazol-5-yl]diazenyl]-3-methylpyrazol-1-yl]-6-hydroxy-1,3,5-triazin-2-yl]-3-methylpyrazol-4-yl]diazenyl]-4-cyanopyrazol-1-yl]-2,5-dichlorobenzenesulfonic acid;tetrakis(carbon dioxide) is sourced from PubChem (CID 159053457), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).